Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC

NCT03432949 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer

Interventions

DRUG: Dexamethasone plus Radium-223

Sponsor

University Health Network, Toronto

Collaborators

[object Object]